Case-based course delves into latest treatment approaches
Patients with a prior history of VTA are at an increased risk of subsequent incidents, despite treatment with therapeutic anticoagulation
Number of stent layers correlates with worse outcomes
Single-cell next-gen sequencing showing promise to improve sensitivity of MRD testing
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dynamic risk assessment may aid clinicians in helping support informed treatment decisions
An innovative approach to protecting patients during breast and lung radiation therapy
Driving advances in cancer care
Regular surveillance necessary to identify safety signals
Potential treatment option for patients who are ineligible for cisplatin
Blood-based assay could alleviate barriers to lung cancer screening
Advertisement
Advertisement